Fangchinoline Protects Against Renal Injury in Diabetic Nephropathy by Modulating the MAPK Signaling Pathway
Authors:
- 26 July 2018
- journal article
- research article
- Published by Georg Thieme Verlag KG in Experimental and Clinical Endocrinology & Diabetes
- Vol. 128 (08) , 499-505
Abstract
In this study, we evaluated the nephroprotective effects of fangchinoline in rats with diabetic nephropathy (DN). DN was induced by feeding a high-fat diet for 4 weeks and administering a single dose of streptozotocin (STZ) (30 mg/kg) intraperitoneally. The rats were split into groups; one group received oral fangchinoline (3 mg/kg) per day for 8 weeks. After completion of the 8-week study period, biomedical and inflammatory markers were evaluated in serum and urine, and oxidative stress was estimated in kidney tissues. In addition, Western blot assays, reverse transcription-polymerase chain reaction, and immunohistochemical analyses were performed in the kidney tissues of DN rats. The results suggest that treatment with fangchinoline attenuated the biochemical marker changes induced by DN in blood and urine. Moreover, a significant (p<0.01) reduction in inflammatory markers in serum was found in the fangchinoline group compared to the controls. Immunohistochemical analyses also revealed that treatment with fangchinoline significantly reduced the expression of collagen IV and CD31 in the kidneys compared to the control group. The expression of p38 MAPK, TNF-α, COX-2, and MMP-9 was also attenuated by fangchinoline treatment in the kidney tissues of DN rats. Together, the results of this study suggest that fangchinoline protects against nephron damage by attenuating alterations in the p38 MAPK pathway, thereby reducing oxidative stress and inflammation in DN rats.Keywords
This publication has 16 references indexed in Scilit:
- Pro-inflammatory cytokines: a possible relationship with dialytic adequacy and serum albumin in peritoneal dialysis patientsClinical Kidney Journal, 2015
- Anti-Inflammatory Role of MicroRNA-146a in the Pathogenesis of Diabetic NephropathyJournal of the American Society of Nephrology, 2015
- Inhibition to DRP1 translocation can mitigate p38 MAPK-signaling pathway activation in GMC induced by hyperglycemiaRenal Failure, 2015
- Diabetic nephropathy – complications and treatmentInternational Journal of Nephrology and Renovascular Disease, 2014
- Review article: the role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseasesNaunyn-Schmiedeberg's Archives of Pharmacology, 2014
- PREPARATIVE ISOLATION OF TETRANDRINE AND FANGCHINOLINE FROM RADIX STEPHANIA TETRANDRA USING REVERSED-PHASE FLASH CHROMATOGRAPHYJournal of Liquid Chromatography & Related Technologies, 2013
- Diabetic Nephropathy and Extracellular MatrixJournal of Histochemistry & Cytochemistry, 2012
- Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein KinasesMicrobiology and Molecular Biology Reviews, 2011
- High expression of PKC-MAPK pathway mRNAs correlates with glomerular lesions in human diabetic nephropathyKidney International, 2004
- Expression of transforming growth factor-beta and type IV collagen in early streptozotocin-induced diabetesDiabetes, 1997